Cai L, Tu L, Li T, Yang X, Ren Y, Gu R, Zhang Q, Yao H, Qu X, Wang Q, Tian J (2019) Downregulation of lncRNA UCA1 ameliorates the damage of dopaminergic neurons, reduces oxidative stress and inflammation in Parkinson’s disease through the inhibition of the PI3K/Akt signaling pathway. Int Immunopharmacol 75:105734
CAS
Article
Google Scholar
Choudhary NS, Duseja A (2021) Genetic and epigenetic disease modifiers: non-alcoholic fatty liver disease (NAFLD) and alcoholic liver disease (ALD). Transl Gastroenterol Hepatol 6:2
Article
Google Scholar
Del Campo JA, Gallego P, Grande L (2018) Role of inflammatory response in liver diseases: therapeutic strategies. World J Hepatol 10:1–7
Article
Google Scholar
Huang X, Gao Y, Qin J, Lu S (2018) lncRNA MIAT promotes proliferation and invasion of HCC cells via sponging miR-214. Am J Physiol Gastrointest Liver Physiol 314:G559–G565
CAS
Article
Google Scholar
Kakino S, Ohki T, Nakayama H, Yuan X, Otabe S, Hashinaga T, Wada N, Kurita Y, Tanaka K, Hara K, Soejima E, Tajiri Y, Yamada K (2018) Pivotal role of TNF-alpha in the development and progression of nonalcoholic fatty liver disease in a murine model. Horm Metab Res 50:80–87
CAS
Article
Google Scholar
Klop B, do Rego AT, Cabezas MC (2013) Alcohol and plasma triglycerides. Curr Opin Lipidol 24:321–326
CAS
Article
Google Scholar
Kong LZ, Chandimali N, Han YH, Lee DH, Kim JS, Kim SU, Kim TD, Jeong DK, Sun HN, Lee DS, Kwon T (2019) Pathogenesis, early diagnosis, and therapeutic management of alcoholic liver disease. Int J Mol Sci 20
Krol J, Loedige I, Filipowicz W (2010) The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet 11:597–610
CAS
Article
Google Scholar
Lin CJ, Hu ZG, Yuan GD, Lei B, He SQ (2018) Complements are involved in alcoholic fatty liver disease, hepatitis and fibrosis. World J Hepatol 10:662–669
Article
Google Scholar
Liu Y, Guo B, Aguilera-Jimenez E, Chu VS, Zhou J, Wu Z, Francis JM, Yang X, Choi PS, Bailey SD, Zhang X (2020) Chromatin looping shapes KLF5-dependent transcriptional programs in human epithelial cancers. Cancer Res 80:5464–5477
CAS
Article
Google Scholar
Mattick JS, Rinn JL (2015) Discovery and annotation of long noncoding RNAs. Nat Struct Mol Biol 22:5–7
CAS
Article
Google Scholar
Meroni M, Longo M, Rametta R, Dongiovanni P (2018) Genetic and epigenetic modifiers of alcoholic liver disease. Int J Mol Sci 19
Pan W, Li W, Zhao J, Huang Z, Chen S, Wang C, Xue Y, Huang F, Fang Q, Wang J, Brand D, Zheng SG (2019) lncRNA-PDPK2P promotes hepatocellular carcinoma progression through the PDK1/AKT/Caspase 3 pathway. Mol Oncol 13:2246–2258
CAS
Article
Google Scholar
Qin LT, Tang RX, Lin P, Li Q, Yang H, Luo DZ, Chen G, He Y, Li P (2018) Biological function of UCA1 in hepatocellular carcinoma and its clinical significance: investigation with in vitro and meta-analysis. Pathol Res Pract 214:1260–1272
CAS
Article
Google Scholar
Rehm J, Samokhvalov AV, Shield KD (2013) Global burden of alcoholic liver diseases. J Hepatol 59:160–168
Article
Google Scholar
Ren F, Ren JH, Song CL, Tan M, Yu HB, Zhou YJ, Qin YP, Cheng ST, Zhang Y, Huang AL, Chen J, Yang X (2020) LncRNA HOTAIR modulates hepatitis B virus transcription and replication by enhancing SP1 transcription factor. Clin Sci 134:3007–3022
CAS
Article
Google Scholar
Ren B, Song Z, Chen L, Niu X, Feng Q (2021) Long non-coding RNA UCA1 correlates with elevated disease severity, Th17 cell proportion, inflammatory cytokines, and worse prognosis in acute ischemic stroke patients. J Clin Lab Anal 35:e23697
CAS
PubMed
PubMed Central
Google Scholar
Rigoutsos I, Furnari F (2010) Gene-expression forum: decoy for microRNAs. Nature 465:1016–1017
CAS
Article
Google Scholar
Schmittgen TD, Livak KJ (2008) Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 3:1101–1108
CAS
Article
Google Scholar
Singal AK, Bataller R, Ahn J, Kamath PS, Shah VH (2018) ACG Clinical Guideline: Alcoholic Liver Disease. Am J Gastroenterol 113:175–194
Article
Google Scholar
Smekalova EM, Kotelevtsev YV, Leboeuf D, Shcherbinina EY, Fefilova AS, Zatsepin TS, Koteliansky V (2016) lncRNA in the liver: prospects for fundamental research and therapy by RNA interference. Biochimie 131:159–172
CAS
Article
Google Scholar
Sugimoto K, Takei Y (2017) Pathogenesis of alcoholic liver disease. Hepatol Res 47:70–79
Article
Google Scholar
Tay Y, Rinn J, Pandolfi PP (2014) The multilayered complexity of ceRNA crosstalk and competition. Nature 505:344–352
CAS
Article
Google Scholar
Tilg H, Moschen AR, Szabo G (2016) Interleukin-1 and inflammasomes in alcoholic liver disease/acute alcoholic hepatitis and nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. Hepatology 64:955–965
CAS
Article
Google Scholar
Vinolo MA, Rodrigues HG, Nachbar RT, Curi R (2011) Regulation of inflammation by short chain fatty acids. Nutrients 3:858–876
CAS
Article
Google Scholar
Wang KC, Chang HY (2011) Molecular mechanisms of long noncoding RNAs. Mol Cell 43:904–914
CAS
Article
Google Scholar
Wang F, Ge J, Huang S, Zhou C, Sun Z, Song Y, Xu Y, Ji Y (2021) KLF5/LINC00346/miR148a3p axis regulates inflammation and endothelial cell injury in atherosclerosis. Int J Mol Med 48
Xue M, Chen W, Li X (2016) Urothelial cancer associated 1: a long noncoding RNA with a crucial role in cancer. J Cancer Res Clin Oncol 142:1407–1419
Article
Google Scholar
Yang H, Li Q, Zhang L, Zhu M, Niu J, Xue F, Yang L, Qu Q, Lao Y, Ding Z, Xiao C, Wang K (2020) LncPRYP4-3 serves as a novel diagnostic biomarker for dissecting subtypes of metabolic associated fatty liver disease by targeting RPS4Y2. Clin Exp Med 20:587–600
Article
Google Scholar
Yang Y, Zhao Z, Hou N, Li Y, Wang X, Wu F, Sun R, Han J, Sun H, Song T, Huang C, Shao Y (2017) MicroRNA214 targets Wnt3a to suppress liver cancer cell proliferation. Mol Med Rep 16:6920–6927
CAS
Article
Google Scholar
You M, Arteel GE (2019) Effect of ethanol on lipid metabolism. J Hepatol 70:237–248
CAS
Article
Google Scholar